LETICIA ROCCO: Open Payments
NPI 1982249124 · NEW CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,900 in 287 payments from 19 companies in 2025. Trend: 2023 $1,407 · 2024 $3,700 · 2025 $5,900
Food & beverage: $5,716Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $700 |
| PFIZER INC. | 33 | $598 |
| Incyte Corporation | 14 | $577 |
| UCB, Inc. | 26 | $560 |
| Janssen Biotech, Inc. | 15 | $545 |
| Regeneron Healthcare Solutions, Inc. | 13 | $361 |
| Galderma Laboratories, L.P. | 21 | $335 |
| Botanix SB Inc | 17 | $334 |
| GENZYME CORPORATION | 12 | $322 |
| Organon LLC | 39 | $320 |
Products named: DUPIXENT, OPZELURA, Bimzelx, TREMFYA, SKYRIZI, RINVOQ, SOFDRA, CIBINQO.
Industry payments across NY — which companies pay providers there.
